This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine
Clinical trial NCT03207750 · COMPLETED
Trial details
- NCT number
- NCT03207750
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-14
- Primary completion
- 2018-10-09
- Enrollment
- 1280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.